Loss of taste sensation represents adverse effect compromising nutritional intake and quality-of-life. Ageusia complete loss contrasts dysgeusia altered taste. Chemotherapy agents frequently cause taste changes. Recovery timeframes vary from weeks to years. Nutritional intervention prevents malnutrition.
Patient counselling emphasises dietary coping strategies. Taste-masking formulations improve palatability. Taste modifier use enhances food acceptability. Regulatory labelling highlights taste-related risks. Post-approval surveillance identifies unexpected taste effects.
General Biopharmaceutical Concepts
Loss of Taste Sensation
Loss of taste sensation, or ageusia, is the partial or complete inability to perceive taste that may occur as a disease symptom or treatment-related adverse effect.
Continue Exploring
Browse over 900 biopharmaceutical terms across biologics, ADCs, cell & gene therapy, CMC, clinical development and manufacturing.
Browse Glossary →